Inventor · Paris, FR

Daniel Zagury

25Patents
7h-index
10Co-inventors
66Inventor score

Filing activity: Jun 27, 1994 → Jun 28, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US6093405A Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines Chemistry; Metallurgy 17 Expired
US7022482B2 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses Chemistry; Metallurgy 12 Expired
US8697047B2 Stable immunogenic product comprising antigenic heterocomplexes Human Necessities 11 Active
US6455045B1 Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them Chemistry; Metallurgy 9 Expired
US6132721A Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same Emerging Cross-Sectional Technologies 9 Expired
US7314629B2 Non-immunosuppressive immunogenic or vaccine composition comprising a mutated E7 protein of the HPV-16 virus Chemistry; Metallurgy 8 Expired
US6200575A Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them Emerging Cross-Sectional Technologies 8 Expired
US6878370B1 Chemically modified TNF-α Human Necessities 3 Expired
US7887811B2 Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein Human Necessities 2 Active
US10632186B1 Vaccine to pathogenic immune activation cells during infections Chemistry; Metallurgy 1 Active
US7972603B2 Stable immunogenic product comprising antigenic heterocomplexes Human Necessities 0 Expired
US7351554B2 Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's Chemistry; Metallurgy 0 Active
US11957748B2 Vaccine to pathogenic immune activation cells during infections Chemistry; Metallurgy 0 Active
US7208148B2 Chemically modified cytokines Human Necessities 0 Expired
US8372388B2 Method for preparing a stable TNF-α vaccine Human Necessities 0 Active
US8679483B2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine Chemistry; Metallurgy 0 Active
US7067246B1 Method for determining prognosis of HIV infected individuals Physics 0 Expired
US12024558B2 Method of inhibiting HIV-1 viral rebound in a subject using interferon inhibitors and ART Chemistry; Metallurgy 0 Active
US11077185B2 Vaccine to pathogenic immune activation cells during infections Chemistry; Metallurgy 0 Active
US11198851B2 Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic uses thereof Chemistry; Metallurgy 0 Active
US11365392B2 Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cells and therapeutic uses thereof Chemistry; Metallurgy 0 Active
US8101165B2 Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors Human Necessities 0 Active
US6228890A Use of alicyclic diamines as immunomodulators Emerging Cross-Sectional Technologies 0 Expired
US7015016B2 Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory IgA's Chemistry; Metallurgy 0 Expired
US7504479B2 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.